Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread. A new study from the ...

CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair ...

A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...

Scientists discovered a molecular switch that may reverse cancer cells, stopping them from growing abnormally.

KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

A patient has achieved over 18 years of remission from neuroblastoma, a type of nerve cell cancer, following treatment with ...

Researchers have developed light-sensitive chemicals that can eliminate tumors in vivo in mouse models of breast cancer with ...

Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

Professor Kwang-Hyun Cho's research team has recently been highlighted for their work on developing an original technology ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...